throbber
Anesthesiology 2000; 93:1045–52
`
`© 2000 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc.
`
`Addition of Sodium Bicarbonate to Lidocaine
`Decreases the Duration of Peripheral Nerve
`Block in the Rat
`Catherine J. Sinnott, B.A.,* Joseph M. Garfield, M.D.,* Johannes G. Thalhammer, D.V.M.,†
`Gary R. Strichartz, Ph.D.*‡
`
`MANY anesthesiologists believe that adding sodium bi-
`carbonate to plain lidocaine hydrochloride can enhance
`the efficacy of this local anesthetic. This topic has been
`most widely investigated in epidural anesthesia. Studies
`have shown that adding sodium bicarbonate to lidocaine
`hydrochloride without epinephrine improves the quality
`of epidural block, whereas adding sodium bicarbonate to
`lidocaine with epinephrine does not. The addition of
`8.4% sodium bicarbonate to 2% lidocaine hydrochloride
`without epinephrine (1:10, vol:vol) was shown to de-
`crease onset time1,2 and enhance the depth of epidural
`block at L4 –S1.2 When bicarbonate was added to 2%
`lidocaine hydrochloride with epinephrine (1:200,000),
`neither onset time nor depth of epidural block at L4 –S1
`roots was altered.3
`Most clinical investigators addressing this question have
`used epidural anesthesia as their paradigm. Accordingly,
`the clinical literature remains unclear as to whether adding
`sodium bicarbonate to either plain lidocaine or lidocaine
`with epinephrine improves the quality of peripheral
`nerve block. In addition, the effect of bicarbonate on
`lidocaine’s onset of action in peripheral nerve block
`remains controversial. For example, Chow et al.4 found
`that adding 8.4% sodium bicarbonate to 1.5% lidocaine
`hydrochloride (1:10) with epinephrine (1:200,000) did
`not speed the onset of analgesia in axillary brachial
`plexus block. However, adding sodium bicarbonate at
`the same concentration and volume ratio to 2% lido-
`caine, with and without epinephrine (1:100,000), did
`decrease the onset time of peribulbar anesthesia.5 Apart
`from effects on onset, the actions of bicarbonate on the
`depth and duration of peripheral nerve block with lido-
`caine has not been previously described.
`In the present study we used a well-defined laboratory
`model, i.e., sciatic nerve block in the rat,6,7 to address
`the effect of sodium bicarbonate on peripheral nerve
`block performed with lidocaine. We compared onset
`time, degree of impairment of nociception, i.e., depth of
`analgesia, and block duration with different lidocaine solu-
`tions in rats receiving percutaneous sciatic nerve blocks.
`Lidocaine solutions, with and without epinephrine, were
`prepared from either crystalline salt or from a commercially
`available source (Abbott Laboratories, North Chicago, IL).
`These solutions were either not alkalinized (plain lido-
`caine), alkalinized with sodium bicarbonate, or alkalinized
`with sodium hydroxide (NaOH).
`
`Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/93/4/1045/401400/0000542-200010000-00028.pdf by guest on 08 October 2020
`
`Background: Adding sodium bicarbonate to lidocaine to en-
`hance its efficacy during peripheral nerve block is controver-
`sial. The authors studied the effect of adding sodium bicarbon-
`ate to lidocaine with and without epinephrine versus equivalent
`alkalinization by sodium hydroxide (NaOH) on onset, degree,
`and duration of peripheral nerve block.
`Methods: Part I examined alkalinization by sodium bicarbon-
`ate versus NaOH to pH 7.8 on 0.5% lidocaine, with and without
`epinephrine (1:100,000), prepared from crystalline salt. Part II
`examined 0.5% and 1.0% commercial lidocaine solutions, with
`and without epinephrine, either unalkalinized or alkalinized
`with sodium bicarbonate or NaOH. With NaOH, pH was adjusted
`to 7.8, but with sodium bicarbonate, no pH adjustments were
`made to simulate clinical conditions.
`Results: In part I, addition of either NaOH or sodium bicar-
`bonate to 0.5% lidocaine without epinephrine produced a faster
`onset than did unalkalinized lidocaine, without effecting degree
`or duration of block. In solutions with epinephrine there were
`no differences in onset, degree, or duration between lidocaine
`alkalinized with sodium bicarbonate versus NaOH. In part II,
`addition of sodium bicarbonate or NaOH to 1.0% commercial
`lidocaine without epinephrine did not accelerate onset com-
`pared with the unalkalinized solution. However, adding sodium
`bicarbonate decreased the degree and duration of block by 25%
`and more than 50%, respectively, compared with lidocaine un-
`alkalinized and alkalinized with NaOH. With epinephrine, so-
`dium bicarbonate hastened onset without effecting degree and
`duration compared with the unalkalinized solution.
`Conclusions: With 1% commercial lidocaine without epineph-
`rine, sodium bicarbonate decreases the degree and duration of
`block. However, in solutions with epinephrine, sodium bicar-
`bonate hastens onset, without effecting degree or duration.
`(Key words: Adjuvant; epinephrine; local anesthesia.)
`
`e
`
`This article is featured in “This Month in Anesthesiology.”
`Please see this issue of ANESTHESIOLOGY, page 5A.
`
`* Pain Research Center, Department of Anesthesiology, Perioperative and Pain
`Medicine, Brigham and Women’s Hospital; † Klinikvorstand, Medizinische Klinik;
`‡ Department of Biological Chemistry and Molecular Pharmacology, Harvard
`Medical School.
`
`Received from the Pain Research Center, Department of Anesthesiology,
`Perioperative and Pain Medicine, Brigham and Women’s Hospital, Boston, Mas-
`sachusetts; the Department of Biological Chemistry and Molecular Pharmacol-
`ogy, Harvard Medical School, Boston, Massachusetts; and Klinikvorstand, Mediz-
`inische Klinik, Veterinarmedizinische Universitat, Wien, Austria. Submitted for
`publication January 12, 2000. Accepted for publication May 18, 2000. Supported
`by grant No. GM 35647 from the US Public Health Service, National Institutes of
`Health, Bethesda, Maryland (to Dr. Strichartz).
`
`Address correspondence to Dr. Strichartz: Pain Research Center, Department
`of Anesthesia, Brigham and Women’s Hospital, Harvard Medical School, Boston,
`Massachusetts 02115. Address electronic mail to: gstrichz@zeus.bwh.harvard.edu.
`Reprints will not be available from the authors. Individual article reprints may be
`purchased through the Journal Web site, www.anesthesiology.org.
`
`Anesthesiology, V 93, No 4, Oct 2000
`
`1045
`
`Exhibit 1111
`Prollenium v. Allergan
`IPR2019-01505 et al.
`
`

`

`1046
`
`SINNOTT ET AL.
`
`Table 1. Composition of Solutions Injected for Sciatic Nerve Block
`
`Name
`
`n
`
`Symbol
`
`Description
`
`pH 6 0.05
`
`0.5% lidocaine HCl (unalkalinized)
`0.5% lidocaine HCl with NaOH
`0.5% lidocaine with 8.4% sodium
`bicarbonate (10;1)
`0.5% lidocaine with epi. (1;100,000) and
`NaOH
`0.5% lidocaine HCl epi. (1;100,000) and
`8.4% sodium bicarbonate (10;1)
`
`0.5% lidocaine HCl (unalkalinized)
`0.5% lidocaine HCl with NaOH
`0.5% lidocaine with 8.4% sodium
`bicarbonate (10;1)
`0.5% lidocaine HCl with epi. (1;100,000)
`(unalkalinized)
`0.5% lidocaine HCl with epi. (1;100,000)
`and 8.4% sodium bicarbonate (10;1)
`
`1% lidocaine HCl (unalkalinized)
`1% lidocaine HCl with NaOH
`1% lidocaine with 8.4% sodium
`bicarbonate (10;1)
`1% lidocaine HCl with epi. (1;200,000)
`(unalkalinized)
`1% lidocaine HCl with epi. (1;200,000)
`and 8.4% sodium bicarbonate (10;1)
`
`5.13
`7.85
`7.85
`
`7.85
`
`7.85
`
`6.58
`7.85
`7.99
`
`6.46
`
`7.85
`
`6.64
`7.85
`7.75
`
`4.46
`
`7.49
`
`(Sigma Chemical, St. Louis, MO) was dissolved in 10 ml
`sterile water (Abbott Laboratories); (2) LOH: 0.5% lidocaine
`hydrochloride alkalinized with NaOH (pH 5 7.85)—50 mg
`lidocaine hydrochloride powder was dissolved in 10 ml
`sterile water, and the pH was adjusted to 7.85 with 30 ml
`(1:333) of 2N NaOH (Fisher Scientific, Pittsburgh, PA);
`(3) LBC: 0.5% lidocaine hydrochloride with 8.4% sodium
`bicarbonate (10:1; pH 5 7.85)—10 ml of 0.55% lido-
`caine hydrochloride was prepared by dissolving 55 mg
`lidocaine hydrochloride in 10 ml sterile water; 10 ml of
`8.4% sodium bicarbonate was prepared by dissolving
`840 mg of sodium bicarbonate powder (Sigma Chemical)
`in 10 ml sterile water, and 1 ml of this solution was added
`to the 10-ml lidocaine solution to make a resultant contain-
`ing 55 mg lidocaine in 11 ml 5 0.5%; (4) LE: 0.5% lidocaine
`with epinephrine (1:100,000) alkalinized with NaOH
`(pH 5 7.85)—100 mg crystalline epinephrine hydrochlo-
`ride (Sigma Chemical) was dissolved in 10 ml sterile water,
`and 10 ml of this (1:100) solution was added to 10 ml of
`0.5% lidocaine (made as above) to achieve a final epi-
`nephrine concentration of 1:100,000; the pH of this
`solution was adjusted to 7.85 with 40 ml (1:250) of 2N
`NaOH; and (5) LBCE: 0.5% lidocaine with epinephrine
`(1:100,000) alkalinized to pH 7.85 with 8.4% sodium
`bicarbonate (10:1) (pH 5 7.85)—this solution was pre-
`pared according to the combined regimens 3 and 4,
`described above. All pHs were measured at room tem-
`perature (20 –22°C) using a Model 611 pH meter (Orion
`
`Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/93/4/1045/401400/0000542-200010000-00028.pdf by guest on 08 October 2020
`
`Part I. 0.5% Solutions prepared from crystalline lidocaine HCl
`(cid:140)
`L
`10
`E
`LOH
`10
`F
`LBC
`10
`
`LE
`
`LBCE
`
`10
`
`10
`
`h
`
`n
`
`Part II. 0.5% Commercial lidocaine HCl solutions
`(cid:140)
`CL
`10
`E
`CLOH
`10
`F
`CLBC
`10
`
`CLE
`
`CLBCE
`
`*CL
`*CLOH
`*CLBC
`
`*CLE
`
`*CLBCE
`
`10
`
`10
`
`h
`
`n
`
`1.0% Commercial lidocaine HCl solutions
`(cid:140)
`10
`E
`10
`F
`9
`
`9
`
`9
`
`h
`
`n
`
`Materials and Methods
`
`Animals
`Male Sprague-Dawley rats (Taconic Farms, German-
`town, NY) weighing 250 –350 g were housed in the
`Brigham and Women’s Hospital animal facilities with a
`12-h light– dark cycle. All behavioral testing and surgical
`procedures in this study were approved by the Harvard
`Medical Area Committee on Animals. All animals used in
`these experiments were handled for 15 min/day for a
`2-week period before the tests to preclude stress-in-
`duced analgesia in rats during experimentation. Han-
`dling procedures involved persistent tactile contact with
`one experimenter (C.J.S.) and several applications of a
`deep pinch with serrated forceps to the fifth metatarsal.6
`
`Experimental Design
`Percutaneous sciatic nerve blocks were performed
`with five lidocaine solutions prepared from either crys-
`talline lidocaine hydrochloride at a concentration of
`0.5% or commercial lidocaine at a concentration of 0.5%
`and 1.0% (Abbott Laboratories; table 1).
`
`Preparation of 0.5% Solutions from Crystalline
`Lidocaine Hydrochloride
`Five 0.5% lidocaine solutions (all exactly 0.5% with
`pH 5 5.13 or 7.85) were prepared from the crystalline
`salt: (1) L: 0.5% plain lidocaine hydrochloride (pH 5
`5.13 6 0.05)—50 mg lidocaine hydrochloride powder
`
`Anesthesiology, V 93, No 4, Oct 2000
`
`

`

`BICARBONATE SHORTENS PERIPHERAL NERVE BLOCK
`
`1047
`
`7.85 with 15 ml (1:667) of 2N NaOH; (3) *CLBC: 1%
`lidocaine hydrochloride alkalinized with 8.4% sodium
`bicarbonate (10:1; pH 5 7.75)—a solution of 1.5% lido-
`caine hydrochloride injection (Abbott Laboratories) was
`diluted to 1.1% with 0.9% NaCl injection; 1 ml of 8.4%
`sodium bicarbonate injection was then added to 10 ml of
`the 1.1% lidocaine solution; (4) *CLE: unalkalinized 1%
`lidocaine hydrochloride with epinephrine (1:200,000)
`injection (Abbott Laboratories; pH 5 4.46); and (5)
`*CLBCE: 1% lidocaine hydrochloride with epinephrine
`(1:200,000) alkalinized with 8.4% sodium bicarbonate
`(10:1; pH 5 7.49)—a solution of 1.5% lidocaine hydro-
`chloride injection was diluted to 1.1% with 0.9% NaCl
`injection; 1 ml of 8.4% sodium bicarbonate injection was
`then added to 10 ml of the 1.1% lidocaine solution, and
`110 ml of epinephrine hydrochloride injection was then
`added to this solution.
`
`Preparation of Commercial Control Solutions
`Three control solutions were prepared for this com-
`ponent of the study. The first contained only 0.9% NaCl
`injection, the second contained 1 ml of 8.4% sodium
`bicarbonate injection combined with 10 ml of 0.9% NaCl
`injection, and the third contained 100 ml of epinephrine
`hydrochloride injection (1:1000) combined with 10 ml
`of 0.9% NaCl injection to make a resultant concentration
`of 1:100,000.
`
`Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/93/4/1045/401400/0000542-200010000-00028.pdf by guest on 08 October 2020
`
`Injection of Lidocaine Solutions
`The injection technique used in this study was the
`same used by Thalhammer et al.6 and Popitz-Bergez et
`al.7 to produce a motor and sensory block of the sciatic
`nerve in a rat. Fifteen groups of rats, each group with
`n 5 9 or 10, received a percutaneous injection with a
`27-gauge needle of 100 ml of one of the 15 lidocaine
`solutions previously described. An additional six groups
`of rats, each with n 5 4, received a percutaneous injec-
`tion of 100 ml of one of six control solutions.
`
`Evaluation of Sensory Functional Deficit
`Analgesia was measured in the ipsilateral limb every 2
`min after injection for up to 40 min, and every 10 min
`thereafter. The neurologic evaluation was a modification
`of the protocol described by Thalhammer et al.6 Noci-
`ception was quantified by evaluating the rat’s with-
`drawal response to a deep pinch (forceful enough to
`reach bone) by serrated forceps at the fifth metatarsal.
`The withdrawal response was graded on an ordinal scale
`of 0 (no withdrawal response) to 4 (a normal, brisk
`withdrawal response). A score of 4 meant a normal
`reaction characterized by a brisk, strong paw with-
`drawal, vocalization, and an attempt to bite the forceps.
`A score of 3 was characterized by a slower, weaker
`withdrawal response, vocalization, and no attempt to
`bite the forceps. A score of 2 corresponded to an even
`
`Research Inc., Boston, MA) with a combination Ag/AgCl-
`glass electrode (Corning Inc., Acton, MA) in a slowly
`stirred solution to minimize vortex-induced dissolution
`of carbon dioxide.
`
`Preparation of Crystalline Control Solutions
`Three control solutions were prepared. The first con-
`tained only sterile water, the second contained epineph-
`rine dissolved in sterile water to a concentration of
`1:100,000 (according to regimen 4), and the third con-
`tained 8.4% sodium bicarbonate dissolved in sterile water
`(according to regimen 3) and diluted to a ratio of 1:10.
`
`Preparation of Commercial 0.5% Lidocaine
`Solutions
`Five 0.5% lidocaine solutions were prepared from com-
`mercially available solutions. The lidocaine concentra-
`tion in all solutions was exactly 0.5%, and in solutions
`with NaOH, pH was adjusted to 7.85. In solutions with
`epinephrine or sodium bicarbonate, there was no inten-
`tional adjustment of pH, in order to simulate clinical
`conditions: (1) CL: 0.5% unalkalinized lidocaine hydro-
`chloride injection (pH 5 6.58); (2) CLOH: 0.5% lidocaine
`hydrochloride alkalinized with NaOH (pH 5 7.85)—10 ml
`of 0.5% lidocaine hydrochloride injection was alkalinized
`with 10 ml (1:1000) of 2N NaOH; (3) CLBC: 0.5% lido-
`caine hydrochloride alkalinized with 8.4% sodium bicar-
`bonate (10:1; pH 5 7.99)—1% lidocaine hydrochloride
`injection (Abbott Laboratories) was diluted to 0.55%
`solution with 0.9% NaCl injection (Abbott Laboratories);
`1 ml of 8.4% sodium bicarbonate injection (Abbott Lab-
`oratories) was added to 10 ml of the 0.55% lidocaine
`solution; (4) CLE: 0.5% unalkalinized lidocaine hydro-
`chloride containing epinephrine (1:100,000) injection
`(Abbott Laboratories; pH 5 6.46); and (5) CLBCE: 0.5%
`lidocaine hydrochloride with 8.4% sodium bicarbonate
`(10:1) and epinephrine (1:100,000) (pH 5 7.85)—1%
`lidocaine hydrochloride injection was diluted to 0.55%
`with 0.9% NaCl injection; 1 ml of 8.4% sodium bicarbon-
`ate injection was added to 10 ml of the 0.55% lidocaine
`hydrochloride solution, and 110 ml of epinephrine hy-
`drochloride (1:1000) injection (American Regent Labo-
`ratories, Shirley, NY) was added to this solution.
`
`Preparation of Commercial 1.0% Lidocaine
`Solutions
`Five 1.0% lidocaine solutions were prepared from com-
`mercially available solutions. The lidocaine concentra-
`tion in all solutions was exactly 1.0%, and in solutions
`with NaOH, pH was adjusted to 7.85. In solutions with
`epinephrine or sodium bicarbonate there was, again, no
`intentional adjustment of pH, to simulate clinical condi-
`tions: (1) *CL: 1% lidocaine hydrochloride injection
`(pH 5 6.64); (2) *CLOH: 1% lidocaine hydrochloride
`alkalinized with NaOH (pH 5 7.85)—10 ml of 1% lido-
`caine hydrochloride injection was alkalinized to pH 5
`
`Anesthesiology, V 93, No 4, Oct 2000
`
`

`

`1048
`
`SINNOTT ET AL.
`
`slower withdrawal response, no vocalization, and no
`biting of the forceps. A score of 1 was characterized by
`a very weak attempt to withdraw. And a score of 0 was
`given when the rat showed none of these responses.
`Previous reports showed that motor block of the sciatic
`nerve could not account for withdrawal response defi-
`cits, proving that true sensory loss was being tested.6
`Analgesia was reported as the mean withdrawal re-
`sponse to deep pinch 6 SD. The duration of block was
`defined as the time until the response returned to a value
`of 3 (75% of normal) after injection. The time of onset
`was the time it took for the response to reach a value of
`2 (50% of normal), from a normal response of 4, after
`injection. The maximum degree of impairment was con-
`sidered the lowest withdrawal response score achieved
`after injection of local anesthetic.
`
`Statistical Analysis
`The duration of onset, the degree of block, and the
`duration of block achieved with lidocaine solutions were
`compared using the Mann–Whitney U rank sum test
`(SPSS Software, Chicago, IL). Only groups of rats receiv-
`ing injection of lidocaine solutions at the same concen-
`tration (either 0.5% or 1.0%) and prepared from the same
`materials (crystalline or commercial
`lidocaine) were
`compared against each other. Furthermore, only pairwise
`comparisons were made between either two groups (those
`receiving injections of lidocaine solutions without epineph-
`rine) or three groups (those receiving injections of lido-
`caine solutions with epinephrine). Therefore, the criterion
`for significance was adjusted, using a Bonferroni approxi-
`mation, to P 5 0.025 for pairwise comparison between
`two groups and P 5 0.017 for pairwise comparison be-
`tween three groups.
`
`Results
`
`Analgesia with 0.5% Crystalline Lidocaine Solutions
`None of the three control solutions (sterile water, 8.4%
`sodium bicarbonate (1:10), or epinephrine (1:100,000)
`produced any impairment of nocifensive function, i.e., a
`normal withdrawal response of 4 was present for 60 min
`after injection. Furthermore, there were no indications
`of motor deficits, such as foot pronation, toe curling, or
`dragging of the limb.
`Considering onset time, alkalinization of 0.5% lido-
`caine without epinephrine by either NaOH (LOH) or
`sodium bicarbonate (LBC) produced a faster onset than
`did unalkalinized lidocaine (L): 3.2 6 1.3 (P 5 0.006)
`and 2.9 6 1.0 min (P 5 0.0024) versus 6.0 6 2.1 min
`(6 SD), respectively (fig. 1). Furthermore, onset times
`with either alkalinizing agent did not differ significantly
`from each other (P 5 0.678). Considering degree of
`block and duration of block, these parameters did not
`differ significantly among the three solutions. Mean val-
`ues (6 SD) of the lowest withdrawal response score
`achieved with the L, LBC, and LOH solutions were 1.2 6
`1.0, 1.0 6 0.8, and 0.4 6 0.7, respectively (P $ 0.059),
`and those for duration of block were 15.0 6 6.2 min,
`11.4 6 3.0 min, and 17.8 6 7.8 min. Duration of block
`achieved with the LBC solution was less, but insignifi-
`cantly so, than that with both L (P 5 0.054) and LOH
`(P 5 0.085).
`When 0.5% crystalline lidocaine with epinephrine
`(1:100,000) was alkalinized to pH 7.85 with either so-
`dium bicarbonate or sodium hydroxide, there were no
`significant differences (P $ 0.1) between the two in
`onset, degree, or duration of block (fig. 2). Mean onset
`times were 2.8 6 1.0 min for both, mean withdrawal
`response scores were 0.0 6 0.0 for LE and 0.2 6 0.3 for
`
`Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/93/4/1045/401400/0000542-200010000-00028.pdf by guest on 08 October 2020
`
`4 • - • - • ♦ ♦ ♦ ♦ ♦ ♦7♦ •--1---•-•-•-• /~
`
`3
`
`2
`
`1
`
`0
`
`~ /
`
`/
`
`ci
`if.)
`ti
`_c
`()
`C
`0:::
`g-
`Q)
`0
`-8
`3l
`C
`0
`Cl.
`(/)
`
`(1) a:
`
`0
`
`2
`
`4
`
`6
`
`8 1 0 12 14 16 18 20 22 24 26 28 30 32 34 36
`Time (Minutes)
`
`Anesthesiology, V 93, No 4, Oct 2000
`
`Fig. 1. Time course of analgesia (inhibition
`of the response to an intense pinch) after
`injection of 0.5% lidocaine hydrochloride
`solutions prepared from crystalline lido-
`caine hydrochloride: plain lidocaine hy-
`drochloride ((cid:140) L; pH 5 5.1; n 5 10); lido-
`caine hydrochloride
`alkalinized with
`NaOH (V LOH; pH 5 7.8; n 5 10); lidocaine
`hydrochloride alkalinized with sodium bi-
`carbonate (v LBC; pH 5 7.8; n 5 10); con-
`trol (» n 5 4).
`
`

`

`BICARBONATE SHORTENS PERIPHERAL NERVE BLOCK
`
`1049
`
`~ 4 . . . . . . . . . . . . . . . -•-•-.11?1~-•
`;:1/
`J,
`
`"
`
`3
`
`/ }
`
`Fig. 2. Time course of analgesia after in-
`jection of 0.5% lidocaine solutions with
`epinephrine prepared from crystalline li-
`docaine hydrochloride: lidocaine hydro-
`chloride with epinephrine (1:100,000)
`and neutralized with NaOH (M LE; pH 5
`7.9; n 5 10);
`lidocaine hydrochloride
`with 8.4% sodium bicarbonate (10:1) and
`epinephrine (1:100,000; m LBCE; pH 5
`7.8; n 5 10); control (» n 5 4).
`
`(1)
`(/)
`C
`0
`Q.
`(/)
`
`(1) a:
`
`0
`
`0
`
`1 0
`
`20
`
`30
`
`40
`
`50
`
`60
`
`70
`
`80
`
`90
`
`Time (Minutes)
`
`1 00 110 120 130
`
`Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/93/4/1045/401400/0000542-200010000-00028.pdf by guest on 08 October 2020
`
`LBCE, and the mean durations of block were 72.0 6 16.0
`min for LE and 61.0 6 13.8 min for LBCE.
`
`Analgesia with 0.5% Commercial Lidocaine
`Solutions
`Sciatic nerve injections with the three control solu-
`tions for this component of the study (see Methods)
`produced no analgesia or motor block indications for 60
`min after injection.
`Regarding onset time, with 0.5% commercial lidocaine
`without epinephrine, i.e., CL, CLBC, and CLOH, it was
`not possible to compare this parameter among the solu-
`tions because several animals never achieved a with-
`drawal response score of 2, which was the criterion for
`onset. Assessment of degree of block showed that alka-
`linization with sodium bicarbonate (CLBC) produced no
`significant difference in degree of analgesia (mean with-
`
`drawal response score was 3.0 6 0.6) compared with
`unalkalinized lidocaine (CL, 2.8 6 1.1; fig. 3). However,
`alkalinization with sodium hydroxide CLOH resulted in a
`significantly greater degree of impairment (1.1 6 1.2)
`than that with CL (P 5 0.017) and CLBC (P 5 0.004).
`With regard to block duration, there were no significant
`differences between unalkalinized lidocaine (13.2 6 8.3
`min) versus that alkalinized with sodium bicarbonate
`(4.6 6 4.6, P 5 0.021) or NaOH (12.8 6 5.5). However,
`block duration with CLBC was significantly less than that
`with CLOH (P 5 0.006).
`Compared with unalkalinized solutions of 0.5% com-
`mercial
`lidocaine with epinephrine (1:100,000; CLE),
`solutions alkalinized with sodium bicarbonate (CLBCE)
`produced no significant differences relative to onset
`(4.0 6 1.3 min for CLE and 3.8 6 1.1 min for CLBCE; P 5
`0.72), degree (a score of 0.0 6 0.0 for both), or duration
`
`Fig. 3. Time course of analgesia after in-
`jection of commercial 0.5% lidocaine so-
`lutions: plain lidocaine hydrochloride ((cid:140)
`CL; pH 5 6.6; n 5 10); lidocaine hydro-
`chloride alkalinized with NaOH (V CLOH;
`pH 5 7.8; n 5 10); lidocaine hydrochlo-
`ride alkalinized with 8.4% sodium bicar-
`bonate (10:1; v CLBC; pH 5 8.0; n 5 10);
`control (» n 5 4).
`
`0
`(/)
`+I
`_r
`0
`C
`[l...
`
`Q.
`
`:ls
`0
`.8
`
`(1)
`(/)
`C
`0
`Q.
`(/)
`
`(1) a:
`
`2
`
`0
`
`Anesthesiology, V 93, No 4, Oct 2000
`
`0
`
`2
`
`4
`
`6
`
`8 1 0 12 14 16 18 20 22 24 26 28 30 32 34 36
`
`Time (Minutes)
`
`

`

`1050
`
`0
`
`0
`
`1 0
`
`20
`
`30
`
`40
`
`50
`
`60
`
`70
`
`80
`
`90
`
`1 00
`
`11 0
`
`1 20 1 30
`
`Time (Minutes)
`
`SINNOTT ET AL.
`
`Fig. 4. Time course of analgesia after in-
`jection of commercial 0.5% lidocaine so-
`lutions with epinephrine: lidocaine with
`epinephrine (1:100,000; M CLE; pH 5 6.5;
`n 5 10);
`lidocaine with epinephrine
`(1:100,000) and 8.4% sodium bicarbonate
`(10:1; m CLBCE; pH 5 7.9; n 5 10); con-
`trol (» n 5 4).
`
`Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/93/4/1045/401400/0000542-200010000-00028.pdf by guest on 08 October 2020
`
`of block (61.0 6 10.4 min for CLE and 57.0 6 7.8 min for
`CLBCE; P 5 0.3845; fig. 4).
`
`Analgesia with 1.0% Commercial Lidocaine
`Solutions
`With 1% commercial lidocaine without epinephrine,
`there were no significant differences relative to onset
`time among the three solutions (fig. 5): CL was 3.2 6 1.0
`min, CLBC was 2.8 6 1.4 min, and CLOH was 2.4 6 0.8
`min; P $ 0.0752. Relative to degree of block, the addi-
`tion of sodium bicarbonate (*CLBC) significantly (P #
`0.011) decreased the degree of block compared with
`both unalkalinized lidocaine (*CL) and lidocaine with
`NaOH (*CLOH). The mean withdrawal response score
`with *CLBC was 0.8 6 0.9, and with *CL and *CLOH it
`was 0.0 6 0.0. Concerning duration of block, the addi-
`
`tion of sodium bicarbonate significantly (P 5 0.0002)
`shortened the duration of block compared with both
`unalkalinized lidocaine and lidocaine alkalinized with
`NaOH. Mean duration of block with *CLBC was 14.4 6
`5.1 min; with *CL it was 55.0 6 13.6 min, and with
`*CLOH it was 38.0 6 6.0 min. The duration of block with
`unalkalinized lidocaine was significantly (P 5 0.004)
`greater than that with NaOH, a finding for which we
`have no ready explanation.
`Adding sodium bicarbonate to 1% lidocaine with epi-
`nephrine (1:200,000) hastened the onset compared with
`unalkalinized (2.4 6 0.8 for *CLBCE vs. 4.4 6 1.3 min for
`*CLE; P 5 0.004; fig. 6). However, the addition of bicar-
`bonate did not significantly (P $ 0.9281) alter the degree
`(a mean withdrawal response score of 0.0 6 0.0 for
`both) or duration of block (75.6 6 18.9 min for *CLE and
`77.8 6 11.3 min for *CLBCE).
`
`Fig. 5. Time course of analgesia after
`injection of commercial 1% lidocaine
`solutions: plain lidocaine hydrochloride
`((cid:140) CL; pH 5 6.6; n 5 10); lidocaine hy-
`drochloride alkalinized with NaOH (V
`CLOH; pH 5 7.8; n 5 10); lidocaine hy-
`drochloride alkalinized with 8.4% so-
`dium bicarbonate (10:1; v CLBC; pH 5
`7.8; n 5 10); control (» n 5 4).
`
`0
`
`10
`
`20
`
`30
`
`60
`50
`40
`Time (Minutes)
`
`70
`
`80
`
`90
`
`100
`
`Anesthesiology, V 93, No 4, Oct 2000
`
`

`

`BICARBONATE SHORTENS PERIPHERAL NERVE BLOCK
`
`1051
`
`Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/93/4/1045/401400/0000542-200010000-00028.pdf by guest on 08 October 2020
`
`20
`
`30
`
`40
`
`50
`
`60
`
`70
`
`80
`
`90
`
`Time (Minutes)
`
`1 00 11 0 120 130
`
`out added epinephrine, the reverse occurs, i.e., block
`duration and degree of analgesia are substantially de-
`creased by the addition of sodium bicarbonate without
`effecting onset, compared with that observed with no
`alkalinization or alkalinization with NaOH. In contrast,
`when 1.0% lidocaine is coinjected with epinephrine,
`bicarbonate hastens onset.
`Our finding that adding sodium bicarbonate to 1%
`commercial lidocaine without epinephrine does not af-
`fect onset time has been previously described in clinical
`studies. It was shown that alkalinization with sodium
`bicarbonate of 2% commercial lidocaine without epi-
`nephrine did not affect the onset of epidural anesthesia8,
`nor did it affect the onset of action of 1% lidocaine
`during subcutaneous injection.9 However, other studies
`have reported conflicting results. Two investigations
`have shown that alkalinization with sodium bicarbonate
`does accelerate the onset time of lidocaine. The addition
`of sodium bicarbonate to 2% lidocaine produced a faster
`onset of epidural block in one study2 and of peribulbar
`anesthesia in another.5 Unfortunately, in none of the
`clinical studies was the injectate pH reported, before or
`after adjuvant addition. No clinical studies report the
`results of addition of NaOH to local anesthetic solutions.
`We wish to point out that NaOH is not approved for
`clinical use as an alkalinizing agent for local anesthetics
`and do not advocate its use for this purpose until rigor-
`ous clinical testing of its safety and efficacy is performed.
`Our finding that sodium bicarbonate may shorten the
`block duration of lidocaine when it is not coinjected
`with epinephrine, compared with unalkalinized and al-
`kalinized with NaOH, conflicts with the results of one
`study. Parham and Pasieka9 showed that adding sodium
`bicarbonate to 1% lidocaine without epinephrine did not
`affect its duration of action after subcutaneous injection.
`Precipitation was considered as a possible explanation
`
`Fig. 6. Time course of analgesia after in-
`jection of commercial 1% lidocaine solu-
`tions with epinephrine: lidocaine with
`epinephrine (1:200,000; M CLE; pH 5 4.5;
`n 5 9); lidocaine with epinephrine (1:
`200,000) and 8.4% sodium bicarbonate
`(10:1; m CLBCE; pH 5 7.5; n 5 9); control
`(» n 5 4).
`
`ci
`Cf)
`ti
`.c
`(.)
`C:
`0:::
`Cl..
`(I)
`(I)
`0
`2
`(I)
`<Ji
`C:
`0
`Cl..
`<Ji
`(I)
`a:
`
`4
`
`3
`
`2
`
`0
`
`\fu
`
`'
`
`0
`
`10
`
`Discussion
`
`The results of our investigation show that the effects of
`sodium bicarbonate on the onset, degree, and duration
`of peripheral nerve block had two discrete manifesta-
`tions: (1) they differed with respect to the presence or
`absence of epinephrine, and (2) they differed with re-
`spect to crystalline versus commercial lidocaine.
`With 1% commercial lidocaine, bicarbonate decreased
`degree and duration, lacking any effect on onset when
`injected without epinephrine. When coinjected with
`epinephrine, however, the reverse occurred: bicarbon-
`ate hastened onset without effecting degree or duration.
`Sodium bicarbonate hastened the onset of block in-
`duced by 0.5% crystalline lidocaine in solutions without
`epinephrine. But with 0.5% commercial lidocaine with-
`out epinephrine, none of the block parameters were
`affected by bicarbonate. With the other commercial
`non– epinephrine-containing solution, i.e., 1% lidocaine
`without epinephrine, bicarbonate did not affect onset
`time but reduced both degree of block (by 25%) and
`duration of block (by . 50%) compared with lidocaine
`unalkalinized and alkalinized with NaOH. Sodium bicar-
`bonate alkalinized the pH of this solution to 7.75 6 0.05.
`The pH of the unalkalinized solution was 6.64 6 0.05,
`whereas that of the solution alkalinized with NaOH was
`7.85 6 0.05. The fact that the pH of the two alkalinized
`solutions are within each other’s error range indicates
`that the effect of bicarbonate on 1% lidocaine is probably
`independent of pH and, rather, a direct effect of bicar-
`bonate itself.
`These results show that the onset of rat peripheral
`nerve block with lidocaine at a low concentration (0.5%)
`may be accelerated by modest alkalinization, from addi-
`tion of either sodium hydroxide or sodium bicarbonate,
`with no perceptible effect on degree or duration. How-
`ever, at higher concentrations of lidocaine (1.0%) with-
`
`Anesthesiology, V 93, No 4, Oct 2000
`
`

`

`1052
`
`SINNOTT ET AL.
`
`alkalinization with sodium bicarbonate reduces pain on
`injection by increasing pH (acidic solutions per se are
`algogenic), decreases onset time, and perhaps produces
`a more complete block by elevating the pH of the lido-
`caine solutions closer to the pKa of this local anesthetic
`(7.8), thus favoring the proportion of the deprotonated,
`membrane-permeant form of the local anesthetic.11,12
`Furthermore, ion trapping of charged local anesthetic
`inside the nerve axons, resulting from axoplasmic acid-
`ification, has also been posited, although experimental
`evidence for this is weak.13 Our investigation has not
`validated the expectation of enhanced blockade, al-
`though the expected physical chemical changes in the
`drug do occur with alkalinization, and lidocaine block of
`nerve impulses in vitro is potentiated by bicarbon-
`ate.13–15 Sodium bicarbonate alkalinization may reduce
`onset time, but it also decreases the degree and duration
`of analgesia. These observations in rats indicate that
`further clinical investigations are necessary to elucidate
`the role of sodium bicarbonate alkalinization of plain
`lidocaine and lidocaine containing epinephrine on the
`quality of peripheral nerve block.
`
`Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/93/4/1045/401400/0000542-200010000-00028.pdf by guest on 08 October 2020
`
`References
`
`1. Fukuda T, Naito H: The effect of pH adjustment of 1% lidocaine on the onset
`of sensory and motor blockade of epidural anesthesia in nonpregnant gyneco-
`logical patients. J Anesth 1994; 8:293– 6
`2. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, Lauber R, Hogstrom H,
`Scaramozzino P, Luginbuhl M, Sieber TJ, Zbinden AM: Adding sodium bicarbon-
`ate to lidocaine enhances the depth of epidural blockade. Anesth Analg 1998;
`86:341–7
`3. Gosteli P, Van Gessel E, Gamulin Z: Effects of pH adjustment and carbon-
`ation of lidocaine during epidural anesthesia for foot and ankle surgery. Anesth
`Analg 199

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket